Macroview Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Macroview Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$343.0 - $410.68 $5,488 - $6,570	16 New	16 $6,000
Q1 2023 Apr 18, 2023	SELL	$283.23 - $323.1 $10,762 - $12,277	-38 Reduced 95.0%	2 $0
Q4 2022 Jan 11, 2023	BUY	$285.76 - $321.48 $10,858 - $12,216	38 Added 1900.0%	40 $0
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $442 - $521	2 New	2 $1,000
Q2 2020 Aug 11, 2020	SELL	$225.48 - $295.8 $2,705 - $3,549	-12 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$199.77 - $247.81 $998 - $1,239	-5 Reduced 29.41%	12 $3,000
Q4 2019 Feb 05, 2020	BUY	$166.71 - $223.91 $2,834 - $3,806	17 New	17 $4,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.